Table 3 Adverse events among groups
Adverse events | Etoricoxib | Celecoxib | Placebo | P-value |
|---|---|---|---|---|
· Gastrointestinal |  |  |  |  |
   Dyspepsia | 1 (2.85) | 0 (0) | 2 (6.25) | 0.436 |
   Flatulence | 0 (0) | 0 (0) | 1 (3.13) | 0.205 |
   Nausea | 1 (2.85) | 0 (0) | 0 (0) | 0.233 |
   Vomiting | 0 (0) | 0 (0) | 2 (6.25) | 0.07 |
   Constipation | 0 (0) | 0 (0) | 3 (9.38) | 0.025* |
· Neurological |  |  |  |  |
   Dizziness | 3 (8.57) | 2 (5.71) | 4 (12.50) | 0.59 |
   Headache | 0 (0) | 1 (2.85) | 2 (6.25) | 0.133 |
· Cardiovascular |  |  |  |  |
   Tachycardia | 2 (5.71) | 0 (0) | 3 (9.38) | 0.52 |
   Hypertension | 3 (8.57) | 2 (5.71) | 5 (15.63) | 0.35 |
· Renal |  |  |  |  |
   Oliguria | 0 (0) | 0 (0) | 1 (3.13) | 0.205 |
· Other |  |  |  |  |
   Fever | 2 (5.71) | 12(34.29) | 11 (34.38) | 0.005* |